previous compound ID: 1557 next compound
InChIKey: ODFJOVXVLFUVNQ-UHFFFAOYSA-N
SMILES: CC(=O)NC1=C(C=CC(=C1)[As](=O)(O)O)O

biological descriptors:

CFTR relevance: weak CFTR corrector

Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 55
"JW Hanrahan" "KA Teske" "R Robert" "GW Carlile" "Y Luo" "DY Thomas" "D Zhang"
ReferenceID: 53
"J Goepp" "JW Hanrahan" "B Kus" "J Liao" "R Robert" "SD Macknight" "GW Carlile" "E Matthes" "D Rotin" "DY Thomas"

chemical graph of compound 1557




CID is 1985
synonyms found at PubChem are:
acetarsol, Acetarsone, Acetphenarsine, Amoebal, Arsaphen, Dynarsan, Stovarsol, Mexyl, 97-44-9, Arsonine, Disparicida, Ginarsol, Gynoplix, Kharophen, Kubarsol, Limarsol, Malagride, Monargan, Osarsole, Osvarsan, Osvarson, Pallicid, Spirocid, Spirozid, Stovarsal, Stovarsolan, Vagisept, Vagoflor, Amarsan, Devegan, Nilacid, Oralcid, Orarsan, Osarsal, Osarsol, Paroxyl, Goyl, Fourneau 190, Acetarsolum, Acetarsolo, Chrlich 594, Ehrlich 594, Osarsolum, Sanogyl, N-Acetyl-4-hydroxy-m-arsanilic acid, Acetarsolo [DCIT], Acetarsol [INN:BAN], 3-Acetamido-4-hydroxybenzenearsonic acid, 3-Acetylamino-4-hydroxyphenylarsonic acid, Acetarsolum [INN-Latin], C8H10AsNO5, 3-Acetamido-4-hydroxy-phenylarsonic acid, UNII-806529YU1N, Acetamino-hydroxyphenyl-arsonsaeure, 190 F, F 190, m-ARSANILIC ACID, N-ACETYL-4-HYDROXY-, EINECS 202-582-3, NSC 13160, 3-Acetamido-4-hydroxyphenylarsonsaeure, BRN 2941984, AI3-16141, MLS000028389, MLS000736495, NSC13160, 806529YU1N, SVC, 3-Acetamido-4-hydroxyphenylarsonic acid, NCGC00094812-01, SMR000058626, (3-acetamido-4-hydroxyphenyl)arsonic acid, DSSTox_CID_25847, DSSTox_RID_81169, DSSTox_GSID_45847, Arsonic acid, (3-(acetylamino)-4-hydroxyphenyl)-, Arsonic acid, [3-(acetylamino)-4-hydroxyphenyl]-, S.V.C., WLN: Q-AS-QO&R DQ CMV1, WLN: Q-AS-QO & R DQ CMV1, CAS-97-44-9, [3-(Acetylamino)-4-hydroxyphenyl]arsonic acid, Acetarsone [INN:NF], Acetarsol (INN), Acetarsol (Acetarsone), Spectrum_000588, Acetarsone, >=99%, Opera_ID_176, Spectrum2_000104, Spectrum3_000595, Spectrum4_000384, Spectrum5_000640, AC1L1CO2, BSPBio_002070, KBioGR_000907, KBioSS_001068, 3-16-00-01132 (Beilstein Handbook Reference), MLS001148100, DivK1c_000002, SCHEMBL156373, SPECTRUM1500616, SPBio_000088, AC1Q5A60, CHEMBL1330792, DTXSID9045847, HMS500A04, KBio1_000002, KBio2_001068, KBio2_003636, KBio2_006204, KBio3_001570, NSC3247, CHEBI:135135, MolPort-003-665-580, NINDS_000002, HMS1921K13, HMS2092E06, HMS2235C23, HMS3371H07, Pharmakon1600-01500616, 64046-96-4 (calcium salt), NSC-3247, Tox21_111336, 7891AF, CCG-39708, NSC-13160, NSC757386, AKOS015894435, Tox21_111336_1, KS-1320, NSC-757386, IDI1_000002, 2-ACETAMINOPHENOL-4-ARSONIC ACID, 5892-48-8 (mono-hydrochloride salt), NCGC00094812-02, NCGC00094812-03, NCGC00094812-05, LS-21674, NCI60_002818, 64046-96-4 (unspecified calcium salt), SBI-0051558.P002, (3-acetamido-4-hydroxy-phenyl)arsonic acid, FT-0621732, 55588-51-7 (unspecified hydrochloride salt), D07110, 33425-EP2274983A1, 33425-EP2305655A2, 33425-EP2311815A1, 33425-EP2371823A1, AB00052127_12, AB00052127_13, SR-01000695452, I04-9258, SR-01000695452-3, W-204159, Arsonic acid, (3-(acetylamino)-4-hydroxyphenyl)- (9CI)